Literature DB >> 7812611

Hydrolysis of iodine labelled urodilatin and ANP by recombinant neutral endopeptidase EC. 3.4.24.11.

Z A Abassi1, E Golomb, R Agbaria, P P Roller, J Tate, H R Keiser.   

Abstract

1. Urodilatin is a 32 amino-acid peptide of similar sequence to atrial natriuretic peptide (ANP), with four additional amino-acids at the N-terminus. Although ANP and urodilatin bind to the same receptors with similar affinities, urodilatin is more active than ANP as a natriuretic agent. Previous studies, using neutral endopeptidase EC 3.4.24.11 (NEP) derived from crude membrane preparations, were inconclusive, but suggested that urodilatin was more resistant than ANP to degradation by this enzyme. In the present study, we compared the degradation rates of [125I]-urodilatin and [125I]-ANP by pure recombinant NEP (rNEP). 2. Incubation of radioactively labelled ANP with rNEP resulted in a much more rapid degradation of the peptide than that for labelled urodilatin. 3. Both phosphoramidon and SQ-28,603, potent inhibitors of NEP, completely protected both peptides from metabolism by rNEP. 4. The circular dichroism spectra of the two peptides indicate that they are very similar and exist largely in unordered or flexible conformations. 5. These results support the relative resistance of urodilatin to NEP, and indicate that urodilatin may be of use as a therapeutic agent, in conditions in which ANP is ineffective.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7812611      PMCID: PMC1510039          DOI: 10.1111/j.1476-5381.1994.tb16194.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo.

Authors:  N Ura; O A Carretero; E G Erdös
Journal:  Kidney Int       Date:  1987-10       Impact factor: 10.612

2.  Effects of atrial natriuretic factor in rats with experimental high-output heart failure.

Authors:  A Hoffman; J C Burnett; A Haramati; J Winaver
Journal:  Kidney Int       Date:  1988-03       Impact factor: 10.612

3.  Urodilatin (CDD/ANP-95-126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (alpha-hANP/CDD-99-126).

Authors:  M Gagelmann; D Hock; W G Forssmann
Journal:  FEBS Lett       Date:  1988-06-20       Impact factor: 4.124

4.  Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.

Authors:  G A Riegger; D Elsner; E P Kromer; C Daffner; W G Forssmann; F Muders; E W Pascher; K Kochsiek
Journal:  Circulation       Date:  1988-02       Impact factor: 29.690

5.  Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase).

Authors:  B Malfroy; W J Kuang; P H Seeburg; A J Mason; P R Schofield
Journal:  FEBS Lett       Date:  1988-02-29       Impact factor: 4.124

6.  A rapid method for the preparation of microvilli from rabbit kidney.

Authors:  A G Booth; A J Kenny
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

7.  The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11.

Authors:  S L Stephenson; A J Kenny
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

8.  Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs.

Authors:  M H Bestle; P Bie
Journal:  Acta Physiol Scand       Date:  1993-09

9.  Inactivation of atrial natriuretic factor by the renal brush border.

Authors:  G M Olins; K L Spear; N R Siegel; H A Zurcher-Neely
Journal:  Biochim Biophys Acta       Date:  1987-07-10

10.  Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.

Authors:  R J Cody; S A Atlas; J H Laragh; S H Kubo; A B Covit; K S Ryman; A Shaknovich; K Pondolfino; M Clark; M J Camargo
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

View more
  3 in total

Review 1.  Natriuretic peptide metabolism, clearance and degradation.

Authors:  Lincoln R Potter
Journal:  FEBS J       Date:  2011-04-07       Impact factor: 5.542

2.  Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis.

Authors:  Rasmus Hvidbjerg Gantzel; Mikkel Breinholt Kjær; Peter Jepsen; Niels Kristian Aagaard; Hugh Watson; Lise Lotte Gluud; Henning Grønbæk
Journal:  World J Hepatol       Date:  2022-04-27

3.  CRRL269: a novel designer and renal-enhancing pGC-A peptide activator.

Authors:  Yang Chen; Gail J Harty; Brenda K Huntley; Seethalakshmi R Iyer; Denise M Heublein; Gerald E Harders; Laura Meems; Shuchong Pan; S Jeson Sangaralingham; Tomoko Ichiki; John C Burnett
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-29       Impact factor: 3.210

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.